Pfizer Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
02-27

DJ Pfizer Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Pfizer Inc. $(PFE)$ slid 1.20% to $26.42 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.01% to 5,956.06 and the Dow Jones Industrial Average falling 0.43% to 43,433.12.

The stock's fall snapped a six-day winning streak.

Pfizer Inc. closed 16.23% short of its 52-week high of $31.54, which the company reached on July 30th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.81% to $163.08, Eli Lilly & Co. $(LLY)$ rose 1.46% to $915.01, and Abbott Laboratories $(ABT)$ rose 0.10% to $135.96.

Trading volume (30.0 M) remained 10.3 million below its 50-day average volume of 40.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 26, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 26, 2025 16:35 ET (21:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10